Seven genes for the prognostic prediction in patients with glioma
- 14 February 2019
- journal article
- research article
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 21 (10) , 1327-1335
Abstract
Glioma is a common malignant tumor of the central nervous system, which is characterized by a low cure rate, high morbidity, and high recurrence rate. Consequently, it is imperative to explore some indicators for prognostic prediction in glioma.Keywords
Funding Information
- National Natural Science Foundation of China (81260370)
This publication has 25 references indexed in Scilit:
- DNA Methylation of the Homeobox Genes PITX2 and SHOX2 Predicts Outcome in Non–small-cell Lung Cancer PatientsDiagnostic Molecular Pathology, 2012
- The Accuracy of Survival Time Prediction for Patients with Glioma Is Improved by Measuring Mitotic Spindle Checkpoint Gene ExpressionPLOS ONE, 2011
- Proteomics of gliomas: Initial biomarker discovery and evolution of technologyNeuro-Oncology, 2011
- SMOC1 Is Essential for Ocular and Limb Development in Humans and MiceThe American Journal of Human Genetics, 2011
- SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspiratesBMC Cancer, 2010
- Patched1 Inhibits Epidermal Progenitor Cell Expansion and Basal Cell Carcinoma Formation by Limiting Igfbp2 ActivityCancer Prevention Research, 2010
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Insulin-like Growth Factors and Their Binding Proteins Define Specific Phases of Myometrial Differentiation During Pregnancy in the Rat1Biology of Reproduction, 2007
- Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic typesLaboratory Investigation, 2006
- The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndromeHuman Molecular Genetics, 2000